Titan Medical Inc, based in Toronto, Canada, has successfully transitioned into an IP licensing company, focusing on generating revenue from its patent portfolio in the surgical robotic industry. With recent licensing agreements and cost-cutting measures, the company is well-positioned to meet its obligations into 2024 and is exploring opportunities for business combinations in biotech, medtech, and other life sciences sectors.
Having terminated its R&D operations, Titan Medical Inc continues to manage payables efficiently and is actively pursuing additional non-exclusive licensing arrangements. The company's strategic shift towards IP licensing reflects its commitment to maximizing the value of its patent portfolio and exploring new avenues for growth and partnerships within the healthcare and technology sectors.
Generated from their website